NEW YORK (GenomeWeb News) - Alnylam Pharmaceuticals said today it has granted a non-exclusive license to the Kreutzer-Limmer family of RNAi patents to GeneDesign, a Japanese supplier of siRNAs.
 
Under the terms of the agreement, GeneDesign has gained the right to provide RNAi research products and services under the patent family, which covers siRNAs and their use in mediating RNAi in mammalian cells.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.